ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea
· Delayed Price · Currency is KRW 77,300
-700 (-0.90%)
Jun 19, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Raw Pharmaceutical Products | 251.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Raw Pharmaceutical Products Growth | 20.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trial Contract Research | 33.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trial Contract Research Growth | -16.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drugs and Generic Drug Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drugs and Generic Drug Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drugs and Generic Drug Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drugs and Generic Drug Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Switzerland | 98.64B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland Growth | -10.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries | 66.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries Growth | 17.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 51.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -1.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 39.84B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 31.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Belgium | 28.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Spain | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|